Z-0107-2026 Class II Ongoing

Recalled by Inpeco S.A. — Lugano

FDA device recall Z-0107-2026 was initiated by Inpeco S.A. on Sep 3, 2025 and is designated Class II. Reason for recall: The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and… The recall status is ongoing. Affected quantity: 1 unit.

Recall details

Product Type
Devices
Report Date
Oct 15, 2025
Initiation Date
Sep 3, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 unit

Product description

FlexLab X (FXX) System. Potassium Test System. in vitro diagnostic

Reason for recall

The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.

Distribution pattern

US distribution to CA & NY.

Code information

PN: FLX-056-40; UDI: 07640172344002: Serial No. FXX.0015.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0107-2026
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Inpeco S.A.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0107-2026. Report a data issue: hello@regdatalab.com.